Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer

As gemcitabine is a key anti-tumor agent for unresectable pancreatic ductal adenocarcinoma (PDAC), it is important to predict the outcomes of gemcitabine chemotherapy. The present study aimed to confirm whether the derived neutrophil-to-lymphocyte ratio (dNLR) is able to predict chemotherapy outcome...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: SUZUKI, REI, TAKAGI, TADAYUKI, HIKICHI, TAKUTO, KONNO, NAOKI, SUGIMOTO, MITSURU, WATANABE, KO, NAKAMURA, JUN, WARAGAI, YUICHI, KIKUCHI, HITOMI, TAKASUMI, MIKA, WATANABE, HIROSHI, OHIRA, HIROMASA
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840986/
https://ncbi.nlm.nih.gov/pubmed/27123132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4381
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky